Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma

The DNA dependant protein kinase (DNA-PK) enzyme plays a major part in the repair of double stranded breaks induced by radiation and hence in the radio-resistance of tumour cells. Inhibitors of DNA-PK have been tested successfully in the past for their ability to sensitize cancer cells to the effect...

Full description

Bibliographic Details
Main Authors: Suraj Radhamani, Ph.D, Rejitha Suraj, Ph.D, Terri Meehan-Andrews, Ph.D, Jasim Al-Rawi, Christopher Bradley, Ph.D
Format: Article
Language:English
Published: Taylor & Francis Group 2017-07-01
Series:Journal of Radiation Research and Applied Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1687850717300262
id doaj-bffb1019dfdc44d5b1c86afc7875988a
record_format Article
spelling doaj-bffb1019dfdc44d5b1c86afc7875988a2020-11-25T00:54:19ZengTaylor & Francis GroupJournal of Radiation Research and Applied Sciences1687-85072017-07-0110320421310.1016/j.jrras.2017.04.008Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinomaSuraj Radhamani, Ph.D0Rejitha Suraj, Ph.D1Terri Meehan-Andrews, Ph.D2Jasim Al-Rawi3Christopher Bradley, Ph.D4School of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, AustraliaSchool of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, AustraliaLa Trobe Rural Health School, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, AustraliaSchool of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, AustraliaSchool of Pharmacy and Applied Science, Latrobe Institute of Molecular Sciences, La Trobe University, P.O. Box 199, Bendigo, VIC, 3552, AustraliaThe DNA dependant protein kinase (DNA-PK) enzyme plays a major part in the repair of double stranded breaks induced by radiation and hence in the radio-resistance of tumour cells. Inhibitors of DNA-PK have been tested successfully in the past for their ability to sensitize cancer cells to the effects of radiation. Here we present two novel benzoxazines (LTU28 and LTU31) and analyse their ability to cause sensitization of cancer cells to radiation. There was a significant reduction in survival rate, increase in apoptosis and inhibition in autophosphorylation of DNA-PK and AKT1 after treating them with LTU28 concomitantly with radiation. The mechanism of action by LTU28 appears to be through inhibition of DNA-PK leading to delayed DNA repair and promotion of apoptosis. LTU31 showed an inhibition in the phosphorylation of BRCA1, thereby blocking DNA repair by homologous recombination.http://www.sciencedirect.com/science/article/pii/S1687850717300262RadiosensitizingDNA-PKBRCA1Apoptosis
collection DOAJ
language English
format Article
sources DOAJ
author Suraj Radhamani, Ph.D
Rejitha Suraj, Ph.D
Terri Meehan-Andrews, Ph.D
Jasim Al-Rawi
Christopher Bradley, Ph.D
spellingShingle Suraj Radhamani, Ph.D
Rejitha Suraj, Ph.D
Terri Meehan-Andrews, Ph.D
Jasim Al-Rawi
Christopher Bradley, Ph.D
Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
Journal of Radiation Research and Applied Sciences
Radiosensitizing
DNA-PK
BRCA1
Apoptosis
author_facet Suraj Radhamani, Ph.D
Rejitha Suraj, Ph.D
Terri Meehan-Andrews, Ph.D
Jasim Al-Rawi
Christopher Bradley, Ph.D
author_sort Suraj Radhamani, Ph.D
title Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
title_short Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
title_full Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
title_fullStr Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
title_full_unstemmed Radiosensitizing activity of novel small molecule BRCA1 and DNA-PK inhibitors in lung and colon carcinoma
title_sort radiosensitizing activity of novel small molecule brca1 and dna-pk inhibitors in lung and colon carcinoma
publisher Taylor & Francis Group
series Journal of Radiation Research and Applied Sciences
issn 1687-8507
publishDate 2017-07-01
description The DNA dependant protein kinase (DNA-PK) enzyme plays a major part in the repair of double stranded breaks induced by radiation and hence in the radio-resistance of tumour cells. Inhibitors of DNA-PK have been tested successfully in the past for their ability to sensitize cancer cells to the effects of radiation. Here we present two novel benzoxazines (LTU28 and LTU31) and analyse their ability to cause sensitization of cancer cells to radiation. There was a significant reduction in survival rate, increase in apoptosis and inhibition in autophosphorylation of DNA-PK and AKT1 after treating them with LTU28 concomitantly with radiation. The mechanism of action by LTU28 appears to be through inhibition of DNA-PK leading to delayed DNA repair and promotion of apoptosis. LTU31 showed an inhibition in the phosphorylation of BRCA1, thereby blocking DNA repair by homologous recombination.
topic Radiosensitizing
DNA-PK
BRCA1
Apoptosis
url http://www.sciencedirect.com/science/article/pii/S1687850717300262
work_keys_str_mv AT surajradhamaniphd radiosensitizingactivityofnovelsmallmoleculebrca1anddnapkinhibitorsinlungandcoloncarcinoma
AT rejithasurajphd radiosensitizingactivityofnovelsmallmoleculebrca1anddnapkinhibitorsinlungandcoloncarcinoma
AT terrimeehanandrewsphd radiosensitizingactivityofnovelsmallmoleculebrca1anddnapkinhibitorsinlungandcoloncarcinoma
AT jasimalrawi radiosensitizingactivityofnovelsmallmoleculebrca1anddnapkinhibitorsinlungandcoloncarcinoma
AT christopherbradleyphd radiosensitizingactivityofnovelsmallmoleculebrca1anddnapkinhibitorsinlungandcoloncarcinoma
_version_ 1725234836559364096